Bio Green Med Solution insider sale: 92,352 shares at $3.005

Rhea-AI Filing Summary

Bio Green Med Solution (BGMS) reported insider activity on Form 4. Director Datuk Tan Chor How Christopher sold 92,352 shares of common stock on 10/21/2025 at a price of $3.005 per share (transaction code S). Following this sale, the reporting person beneficially owns 279,248 shares, held directly. This filing discloses a change in insider holdings and reflects a single reported transaction.

Insider Trade Summary

Net Seller: 92,352 shares ($277,518)

Net Sell 1 txn

Insider FITTERS Diversified Berhad

Role 10% Owner

Sold 92,352 shs ($278K)

Type	Security	Shares	Price	Value
Sale	Common Stock	92,352	$3.005	$278K

Holdings After Transaction: Common Stock — 279,248 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FITTERS Diversified Berhad

(Last) (First) (Middle)

NO. 1, JALAN TEMBAGA SD 5/2

BANDAR SRI DAMANSARA

(Street)

KUALA LUMPUR N8 52200

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bio Green Med Solution, Inc. [ BGMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/21/2025		S		92,352	D	$3.005	279,248	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Datuk Tan Chor How Christopher	10/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BGMS disclose?

A director sold 92,352 shares of BGMS common stock at $3.005 per share on 10/21/2025 (code S).

Who is the reporting person in BGMS’s Form 4?

The reporting person is Datuk Tan Chor How Christopher, identified as a Director.

How many BGMS shares does the insider hold after the sale?

The insider beneficially owns 279,248 shares following the reported transaction, held directly.

What was the price per share in the BGMS insider sale?

The reported sale price was $3.005 per share.

What is the transaction code used in the BGMS Form 4?

The transaction is labeled with code S, indicating a sale of securities.

What type of security was involved in the BGMS insider trade?

The transaction involved Common Stock of Bio Green Med Solution, Inc.